Go back

Infectious disease funding ‘follows the headlines’

Emerging disease R&D rose in recent years but still left world ill-prepared for Covid-19

Global funding for research on diseases with the potential to cause pandemics needs to be overhauled to become less reactive, less focussed on vaccines and supported by broader range of funders.

That is the conclusion of a comprehensive report on the global landscape of R&D funding for emerging infectious diseases from Policy Cures Research.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.